A. Ito

发表

Extracorporeal cardiac shock wave therapy ameliorates myocardial ischemia in patients with severe coronary artery disease

K. Sunagawa, A. Takeshita, H. Shimokawa, 2006, Coronary artery disease.

Antiplatelet therapy and long-term clinical outcome after sirolimus-eluting stent implantation: 5-year outcome of the j-Cypher registry

H. Fujita, M. Nobuyoshi, Takeshi Kimura, 2012, Cardiovascular Intervention and Therapeutics.

Comparison of three-year clinical outcomes after sirolimus-eluting stent implantation among insulin-treated diabetic, non-insulin-treated diabetic, and non-diabetic patients from j-Cypher registry.

Takeshi Kimura, T. Morimoto, K. Nakao, 2011, The American journal of cardiology.

Sirolimus-Eluting Stent Versus Balloon Angioplasty for Sirolimus-Eluting Stent Restenosis: Insights From the j-Cypher Registry

Takeshi Kimura, T. Morimoto, H. Shiomi, 2010, Circulation.

Prognostic Effects of Benidipine in Patients With Vasospastic Angina: Comparison With Diltiazem and Amlodipine

H. Shimokawa, Y. Fukumoto, S. Yasuda, 2008, Journal of cardiovascular pharmacology.

Coronary Microvascular Dysfunction in Patients With Microvascular Angina: Analysis by TIMI Frame Count

K. Sunagawa, H. Shimokawa, Y. Fukumoto, 2005, Journal of cardiovascular pharmacology.

Coronary Artery Spasm Does Not Depend on the Intracellular Calcium Store but Is Substantially Mediated by the Protein Kinase C–Mediated Pathway in a Swine Model With Interleukin-1β In Vivo

A. Takeshita, H. Shimokawa, Y. Fukumoto, 1996 .

Role of protein kinase C-mediated pathway in the pathogenesis of coronary artery spasm in a swine model.

A. Takeshita, H. Shimokawa, K. Egashira, 1994, Circulation.

Anti-ischemic Effects of Fasudil, a Specific Rho-Kinase Inhibitor, in Patients With Stable Effort Angina

A. Takeshita, Y. Hirooka, H. Shimokawa, 2007, Journal of cardiovascular pharmacology.

The role of fibroblast growth factor-2 in the vascular effects of interleukin-1 beta in porcine coronary arteries in vivo.

A. Takeshita, K. Sueishi, H. Shimokawa, 1996, Cardiovascular research.

Tyrosine Kinase Inhibitor Suppresses Coronary Arteriosclerotic Changes and Vasospastic Responses Induced by Chronic Treatment with Interleukin-lf in Pigs In Vivo changes and vasospastic responses to autacoids

H. Shimokawa, Y. Fukumoto, K. Egashira, 2022 .

Changing Characteristics of Patients with Vasospastic Angina in the Era of New Calcium Channel Blockers

H. Shimokawa, Y. Fukumoto, A. Ito, 2004, Journal of cardiovascular pharmacology.

Acute vasodilator effects of a Rho-kinase inhibitor, fasudil, in patients with severe pulmonary hypertension

A. Takeshita, H. Shimokawa, Y. Fukumoto, 2005, Heart.

Chronic inhibition of endothelium-derived nitric oxide synthesis causes coronary microvascular structural changes and hyperreactivity to serotonin in pigs.

A. Takeshita, K. Sueishi, H. Shimokawa, 1995, Circulation.

Effects of L-arginine analogues on vasomotion of isolated porcine coronary arteries.

A. Takeshita, H. Shimokawa, K. Egashira, 1995, The American journal of physiology.

Coronary artery spasm does not depend on the intracellular calcium store but is substantially mediated by the protein kinase C-mediated pathway in a swine model with interleukin-1 beta in vivo.

A. Takeshita, H. Shimokawa, Y. Fukumoto, 1996, Circulation.

Usefulness of Fasudil, a Rho-kinase Inhibitor, to Treat Intractable Severe Coronary Spasm after Coronary Artery Bypass Surgery

H. Shimokawa, Y. Fukumoto, A. Shiose, 2004, Journal of cardiovascular pharmacology.

Possible involvement of macrophage-colony stimulating factor in the pathogenesis of cardiac dysfunction in hemodialysis patients.

H. Shimokawa, A. Ito, H. Meno, 2004, Japanese heart journal.

Renin-angiotensin system is involved in the mechanism of increased serum asymmetric dimethylarginine in essential hypertension.

A. Takeshita, K. Egashira, A. Ito, 2001, Japanese circulation journal.

Tyrosine kinase inhibitor suppresses coronary arteriosclerotic changes and vasospastic responses induced by chronic treatment with interleukin-1 beta in pigs in vivo.

A. Takeshita, H. Shimokawa, Y. Fukumoto, 1995, The Journal of clinical investigation.

Chronic treatment with interleukin-1 beta induces coronary intimal lesions and vasospastic responses in pigs in vivo. The role of platelet-derived growth factor.

A. Takeshita, H. Shimokawa, Y. Fukumoto, 1996, The Journal of clinical investigation.

Disappearance of coronary artery-ventricular fistulas after a radical operation for tetralogy of Fallot.

A. Takeshita, H. Shimokawa, M. Mohri, 1996, Japanese circulation journal.

Prospective, Multicenter, Randomized Trial to ssess Efficacy of Pioglitazone on In-Stent eointimal Suppression in Type 2 Diabetes OPPS (Prevention of In-Stent Neointimal Proliferation by Pioglitazone Study)

P. Fitzgerald, M. Yoshiyama, Yoshiki Kobayashi, 2022 .

Inflammatory cytokines cause coronary arteriosclerosis-like changes and alterations in the smooth-muscle phenotypes in pigs.

Y. Yazaki, A. Takeshita, Y. Yonemitsu, 1997, Journal of cardiovascular pharmacology.

Angiotensin-converting enzyme activity is involved in the mechanism of increased endogenous nitric oxide synthase inhibitor in patients with type 2 diabetes mellitus.

A. Takeshita, K. Egashira, A. Ito, 2002, Circulation journal : official journal of the Japanese Circulation Society.

Tyrosine kinase inhibitor markedly suppresses the development of coronary lesions induced by long-term treatment with platelet-derived growth factor in pigs in vivo.

A. Takeshita, H. Shimokawa, Y. Fukumoto, 1997, Journal of cardiovascular pharmacology.

The role of fibroblast growth factor-2 in the vascular effects of interleukin-1 / 3 in porcine coronary arteries in vivo 1

K. Sueishi, H. Shimokawa, Y. Fukumoto, 2006 .